BRIEF-ORIC Pharmaceuticals Q4 Net Income USD -36.307 Million

Reuters
19 Feb
BRIEF-ORIC Pharmaceuticals Q4 Net Income USD -36.307 Million

Feb 18 (Reuters) - ORIC Pharmaceuticals Q4 operating expenses USD 39.57 million.

  • Q4 income from operations USD -39.57 million
  • Q4 basic EPS USD -0.51 vs. IBES estimate USD -0.51

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10